Your browser doesn't support javascript.
loading
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.
Ignatiadis, Michail; Rack, Brigitte; Rothé, Francoise; Riethdorf, Sabine; Decraene, Charles; Bonnefoi, Hervé; Dittrich, Christian; Messina, Carlo; Beauvois, Melanie; Trapp, Elisabeth; Goulioti, Theodora; Tryfonidis, Konstantinos; Pantel, Klaus; Repollet, Madeline; Janni, Wolfgang; Piccart, Martine; Sotiriou, Christos; Litiere, Saskia; Pierga, Jean-Yves.
Afiliação
  • Ignatiadis M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: michail.ignatiadis@bordet.be.
  • Rack B; Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany.
  • Rothé F; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany.
  • Decraene C; Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France.
  • Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Dittrich C; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria.
  • Messina C; Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland.
  • Beauvois M; European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Trapp E; Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany.
  • Goulioti T; Breast International Group Headquarters, Brussels, Belgium.
  • Tryfonidis K; European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Pantel K; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany.
  • Repollet M; Janssen Diagnostics LLC, NJ, USA.
  • Janni W; Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany.
  • Piccart M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Litiere S; European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Pierga JY; Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France.
Eur J Cancer ; 63: 97-104, 2016 08.
Article em En | MEDLINE | ID: mdl-27289552
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biópsia / Neoplasias da Mama / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biópsia / Neoplasias da Mama / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido